Can-Fite BioPharma Ltd.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Can-Fite BioPharma Ltd.'s past years’ income statements indicate that its last revenue has decreased compared to the previous period by 8% to $743,000. The net income raised on -$7,634,000 and profit margin reached -1027%. Total operating expenses were $8,938,000.
Profit Margin
| 2014 | 0 | -6.09M | |
|---|---|---|---|
| 2015 | 164.71K | -6.24M | -3790.14% |
| 2016 | 169.5K | -6.89M | -4069.33% |
| 2017 | 844.74K | -6.33M | -750.4% |
| 2018 | 3.82M | -6.57M | -172.02% |
| 2019 | 2.03M | -13.05M | -642.32% |
| 2020 | 763K | -14.44M | -1892.92% |
| 2021 | 853K | -12.59M | -1476.55% |
| 2022 | 810K | -10.23M | -1263.7% |
| 2023 | 743K | -7.63M | -1027.46% |
CANF Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 743K | 810K | 853K | 763K | 2.03M | 3.82M | 844.74K | 169.5K | 164.71K | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 743K | 810K | 853K | 763K | 2.03M | 3.82M | 844.74K | 169.5K | 164.71K | 0 |
Operating exp. | ||||||||||
Research and development | 5.98M | 7.76M | 9.85M | 11.95M | 10.97M | 6.07M | 5.27M | 6.07M | 3.85M | 4.16M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 31.07K | 0 | 0 | 0 |
Total operating expenses | 8.93M | 10.90M | 13.69M | 14.90M | 14.03M | 9.23M | 8.22M | 8.80M | 6.57M | 7.13M |
Operating income | -8.19M | -10.09M | -12.84M | -14.13M | -12.00M | -5.41M | -7.37M | -8.63M | -6.41M | -7.13M |
Other income (expenses), net | 561K | -77K | 227K | -304K | -618K | -759K | 781K | 1.64M | 1.39M | 840.28K |
Income before tax | -7.63M | -10.17M | -12.61M | -14.44M | -12.62M | -6.56M | -4.95M | -6.99M | -5.06M | -6.29M |
Income tax expense | 0 | 63K | -20K | 363K | 427K | 4K | 29.92K | 29.11K | 4.35K | 5.90K |
Net income | -7.63M | -10.23M | -12.59M | -14.44M | -13.05M | -6.57M | -6.33M | -6.89M | -6.24M | -6.09M |
Earnings per share | ||||||||||
Basic EPS | -1.79 | -3.76 | -6.83 | -0.04 | -45.58 | -0.17 | -0.19 | -0.25 | -0.27 | -0.35 |
Diluted EPS | -1.79 | -3.76 | -6.83 | -0.04 | -45.58 | -0.17 | -0.19 | -0.25 | -0.27 | -0.35 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |